We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

EN
01-pc.jpg 01-ph.jpg

About BioGerm

  • Company Profile
  • Corporate Culture
  • Development History
  • R&D and Innovation
  • Honors and Accolades
  • Social Responsibility

Focusing on Infectious Disease Diagnostics and Chronic Disease Management

Shanghai BioGerm Medical Technology Co., Ltd. was established in 2017. With "Empowering Doctors, Enhance Life" as its mission, the company is committed to becoming a "world-class diagnostic specialist". Focusing on accurate and rapid disease diagnosis, the company integrates the R&D, production, sales, and services of diagnostic reagents and devices to provide precise and comprehensive solutions.

f1-icon5.svg
Upstream Raw Materials
f1-icon4.svg
Overseas Business
f1-icon1.svg
Individual Diagnosis and Treatment
f1-icon3.svg
Home Health
f1-icon2.svg
Mass Epidemic Prevention

Product Philosophy

Creating 4A-Featured Products

f1-icon7.svg
Accurate
High sensitivity, specificity, stability
Accurate
f1-icon9.svg
Accessible
Easy operation, freeing hands
Accessible
f1-icon7.svg
Accelerated
30-minute report generation
Accurate
f1-icon10.svg
Affordable
Multi-target detection in one test
Accurate
233 赵总.png

Subsidiaries

  • f1-imgpc1.jpg
    BioGerm (Qingdao) Medical Technology Co., Ltd.

    Dedicated to public health, with a focus on infectious pathogen surveillance.

  • 01.png
    Shanghai BoJian Medical Laboratory Co., Ltd.

    Focusing on clinical specialized diseases and personalized medicine, providing precise diagnostics and treatment medical services

  • 02.png
    LABNOVATION TECHNOLOGIES, INC.

    With glycated hemoglobin testing as the core, deeply cultivating precise full-lifecycle management of diabetes

  • 03.png
    Shanghai Fryael Biotechnology Co., Ltd.

    Focusing on the R&D of upstream raw material products and methodological development for diagnostic reagents

Corporate Culture

  • f1-imgpc4.jpg

    Customer First

    • Always putting the resolution of customer issues first, communicating proactively, and responding actively

    • Mission must be accomplished without buck-passing; customer issues stop with me

    • Proactively exploring customer needs and providing comprehensive solutions that exceed customer expectations

    • Continuously improving personal capabilities, integrating knowledge with practice, and enhancing the efficiency of resolving customer issues

    • Taking customer evaluation as the core standard for evaluating our work

  • f1-imgpc5.jpg

    Courage to Innovate

    • Break free from mental constraints and dare to be a pioneer.

    • Renew yourself, keep learning, and cultivate new ways of thinking.

    • Speak up actively, act decisively, and consistently deliver meaningful innovations.

    • Embrace change, be inclusive of transformation, and accept it with a positive attitude.

    • Face failure rationally, reflect on your own performance, and make timely adjustments.


  • f1-imgpc6.jpg

    Gratitude and Altruism

    • Help one another, inspire others, and never let your teammates fail.

    • Foster a harmonious and uplifting team atmosphere, and boost team morale.

    • Communicate thoroughly before taking action, and execute resolutely afterward.

    • Be grateful, rely on the company as our foundation, and give back to society.

    • Act selflessly and do your utmost to fulfill social responsibilities.


f1-bgpc1.jpg f1-bgpc1-1.jpg

Development History

  • 05.jpg
    2025

    • 6 NMPA Class III Medical Device Registration Certificates

    • Officially entering a new era of intelligent instrumentation

    • Chemiluminescence product matrix established


  • 04.jpg
    2024

    • 6 NMPA Class III Medical Device Registration Certificates

    • Strategic acquisition of LABNOVATION

    • China Intellectual Property Management System Certification

  • 01.jpg
    2023

    • Establishment of subsidiaries in Qingdao and Shenzhen

    • Chemiluminescence R&D Platform

    • Establishment of Bojie Medical Health X Research Institute

    • Brand IP image launch

    • National Intellectual Property Advantage Enterprise


  • 02.jpg
    2022

    • 3 NMPA Class III Certificates

    • Shanghai SRDI Enterprise

    • Groundbreaking of BioGerm Industrial Park



  • 03.jpg
    2021

    • Shareholding Reform

    • 5 NMPA Class III Certificates

  • 01.jpg
    2020

    • First NMPA Class III Medical Device Registration Certificate

    •  Medical Device Manufacturing License

    •  Immunochromatography Platform



  • f1-imgpc9.jpg
    2019

    • Recognized as a high-tech enterprise

    • Series B Financing

    • Instrument R&D Platform

    • Isothermal PCR Platform


  • f1-imgpc10.jpg
    2018

    • Completed initial round of financing

    • Completed filing for Biosafety Level 2 laboratory

    • Obtained clinical laboratory business license


  • f1-imgpc11.jpg
    2017

    • Shanghai BioGerm established

    • Set up sequencing platform, fluorescence PCR platform, bioinformatics analysis platform


f1-bgpc1.jpg f1-bgpc1-1.jpg
f1-bgpc2.png

R&D and Innovation

Focus on research and breakthrough of core underlying technologies

f1-imgpc11.jpg
4 Major

underlying cutting-edge technologies

BioGerm Medical Health X Research Institute

Focus on research and breakthrough of key raw materials and core underlying technologies for medical diagnosis, accelerating industry-university-research collaboration and translation

f1-imgpc12.jpg
8 Major

Technical Research and Development Platforms

BioGerm R&D Center

Adopt a dual-driven R&D strategy, unlocking technological potential and driving continuous innovation to become the core engine for the company's innovation and development

f1-bgpc3.jpg f1-bgpc3-1.jpg

Honors and Accolades

  • 2026
    National IP Demonstration Enterprise
  • 2024
    Rising Enterprise on the Innovation China List
  • 2023
    Shanghai Private Enterprise Headquarters
  • 2022
    National Intellectual Property Advantage Enterprise
  • 2021
    Shanghai Specialized and Innovative SMEs
  • 2020
    First Prize, Shanghai Science and Technology Award
  • 2019
    High-tech Enterprise
  • 2017-2019
    • Gold Award of the 29th Shanghai Outstanding Invention Selection Competition

    • Top 50 Most Investment-Worthy Startup Enterprises in Shanghai

    • Runner-up in the Startup Group of the Shanghai International Medical Industry Innovation and Entrepreneurship Competition

    • One of the First Batch of Top 100 Sci-Tech Innovation Enterprises in Fengxian District

    • National High-Tech Enterprise

    • One of the First Batch of "Three Hundreds" Sci-Tech Innovation Top 100 Enterprises by Fengxian District Government

    • Supported by the Shanghai Service Industry Development Guidance Fund

    • Supported by the Shanghai Zhangjiang Special Development Fund



  • 2020-2021
    • Supported by the first and second batches of the Shanghai Zhangjiang Special Development Fund Projects

    • Supported by the Shanghai Zhangjiang Major Special Projects

    • First Prize in the 9th Innovation and Entrepreneurship Competition (certified by the Ministry of Science and Technology)

    • Third Prize in the 2020 4th Innovation and Entrepreneurship Competition

    • Advanced Collective in the Commercial Circulation and Trade Service Industry

    • First Prize of Shanghai Science and Technology Award (First Prize for Scientific and Technological Progress)

    • 2020 Special Contribution Award of Shanghai Industrial Comprehensive Development Zone

    • 2020 Tax Contribution Excellence Award of Shanghai Industrial Comprehensive Development Zone

    • National Advanced Collective in the Fight Against COVID-19 in the Science and Technology System

    • 2021 Shanghai Specialized and Innovative SMEs


  • 2022-2026
    • 4 products selected into the Shanghai Innovative Product Recommendation Catalog

    • Product awarded Grade I in the Scientific and Technological Achievement Evaluation by the General Administration of Customs of China

    • BioGerm Mobile Shelter Laboratory recognized as the Annual Outstanding Medical Team by Wuxi Municipal Government

    • Shanghai Patent Work Pilot and Demonstration Unit

    • Shanghai Industry-Education Integration Pilot Enterprise

    • Ranked 6th in Fengxian Top 100 Wealth Enterprises

    • 6 products selected into the Shanghai Innovative Product Recommendation Catalog

    • Designated as "Shanghai Enterprise Technology Center"


f1-imgpc14.png

Social Responsibility

  • Proprietary Public Welfare Brand
    BioGerm Care
  • Version 1.0 Giving Back to Society
    Donations & Supplies to the Frontlines
  • Version 2.0 Co-building Public Agendas
    Talent Development, Public Welfare Actions
  • Version 3.0 Industry Leadership
    Long-term Public Welfare Themes
  • Proprietary Public Welfare Brand

    BioGerm Care

    • f1-icon6.svg
      2017

      Starting from

    • f1-icon7-1.svg
      100,000+

      Impact Reach

    • f1-icon7-1.svg
      20+

      Charity Initiatives

    f1-imgpc16.jpg
  • Version 1.0 Giving Back to Society

    Donations & Supplies to the Frontlines

    • f1-icon6.svg
      2.75 Million

      Medical Supply Units

    • f1-icon7-1.svg
      10 Million

      Market Value

    01.png
  • Version 2.0 Co-building Public Agendas

    Talent Development, Public Welfare Actions

    • f1-icon6.svg
      Talent Development

      Fudan University BioGerm Excellence Scholarship

    • f1-icon7-1.svg
      Charitable Initiatives

      Chenguang Charity Foundation

    f1_img096.jpg
  • Version 3.0 Industry Leadership

    Long-term Public Welfare Themes

    f1-imgpc19.jpg

    National Medical Grassroots Public Welfare

    f1-imgpc18.jpg
f1-bgpc1.jpg f1-bgpc1-1.jpg